Jennifer Grossman, PhD is a Contractor Senior Scientific Program Manager in the Vaccine Translation Research Branch (VTRB) in the Division of AIDS of the National Institute of Allergy and Infectious Disease (NIAID), one of the US National Institutes of Health (NIH).
She oversees the production of a portfolio of investigational HIV vaccine products, including antibodies, nanoparticles, protein immunogens, nucleic acides and adjuvants.
Jennifer provides nanotechnology subject matter expertise for R&D, manufacturing, analytics, formulation, Q/A and regulatory support for HIV vaccine products.
Before joining the VTRB, Jennifer was at the National Cancer Institute (NCI), where she led alliance management for the Nanotechnology Characterization Lab (NCL).
There, she established and managed productive collaborations within NCI, FDA, NIST and a network of drug development labs in industry and academia.
Jennifer’s areas of scientific expertise include analytical methods for assessing drug delivery systems and modeling of nanoparticle structures and interactions.
She has experience in a variety of issues related to nanotech drug development and regulation.
Prior to joining the NCL in 2006, Jennifer conducted research in Physical Chemistry at the University of Maryland, where she focused on modeling and measuring protein motion under the guidance of Dr. David Fushman, Professor of Biochemistry. She holds a Ph.D. in Physical Chemistry, an M.S. in Chemical Physics and a B.S. in Physics.